92 related articles for article (PubMed ID: 22098593)
21. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
Furumoto K; Arii S; Mori A; Furuyama H; Gorrin Rivas MJ; Nakao T; Isobe N; Murata T; Takahashi C; Noda M; Imamura M
Hepatology; 2001 Jan; 33(1):189-95. PubMed ID: 11124835
[TBL] [Abstract][Full Text] [Related]
22. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
23. RECK-mediated inhibition of glioma migration and invasion.
Silveira Corrêa TC; Massaro RR; Brohem CA; Taboga SR; Lamers ML; Santos MF; Maria-Engler SS
J Cell Biochem; 2010 May; 110(1):52-61. PubMed ID: 20127710
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive, label-free cell counting and quantitative analysis of adherent cells using digital holography.
Mölder A; Sebesta M; Gustafsson M; Gisselson L; Wingren AG; Alm K
J Microsc; 2008 Nov; 232(2):240-7. PubMed ID: 19017223
[TBL] [Abstract][Full Text] [Related]
25. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between dynamic contrast-enhanced MRI and expression of microvascular density in the glioma].
Yin D; Wang XY; Yan XB; Liao WH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):686-9. PubMed ID: 16708810
[TBL] [Abstract][Full Text] [Related]
28. Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.
Johansson M; Bergenheim AT; Widmark A; Henriksson R
Br J Cancer; 1999 Apr; 80(1-2):142-8. PubMed ID: 10389990
[TBL] [Abstract][Full Text] [Related]
29. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
30. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
Takagi S; Hoshino Y; Osaki T; Okumura M; Fuginaga T
Exp Oncol; 2007 Mar; 29(1):30-4. PubMed ID: 17431385
[TBL] [Abstract][Full Text] [Related]
31. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
32. Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro.
Tian QS; Li DC
Saudi Med J; 2010 Jul; 31(7):752-8. PubMed ID: 20635007
[TBL] [Abstract][Full Text] [Related]
33. Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma.
Mao X; Liu L; Zhang B; Zhang D
Oncol Lett; 2013 Jun; 5(6):1867-1871. PubMed ID: 23833658
[TBL] [Abstract][Full Text] [Related]
34. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
Clark JC; Thomas DM; Choong PF; Dass CR
Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas.
Hori M; Mori H; Aoki S; Abe O; Masumoto T; Kunimatsu S; Ohtomo K; Kabasawa H; Shiraga N; Araki T
Magn Reson Imaging; 2010 May; 28(4):594-8. PubMed ID: 20233645
[TBL] [Abstract][Full Text] [Related]
36. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
[TBL] [Abstract][Full Text] [Related]
37. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of PCDH9 predicts prognosis for patients with glioma.
Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
[TBL] [Abstract][Full Text] [Related]
39. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
Xu J; Wu S; Shi X
J Orthop Res; 2010 Dec; 28(12):1621-5. PubMed ID: 20973064
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
